Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 De Octubre, Madrid

Transplantation Proceedings

Volumn 31, Issue 7 SUPPL. 1, 1999, Pages 75-77

  Morales, J M ^a   Andres A ^a   Morales, E ^a   Herrero, J C ^a   Cubas, A ^a   Praga, M ^a   Hernandez E ^a   Ortuno T ^a   Dominguez Gil, B ^a   Carreno A ^a   Delgado, M ^a   Manzanares, C ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREMOR;

ADRENAL CORTEX HORMONES; ADULT; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; SPAIN; SURVIVAL RATE; TACROLIMUS;

EID: 0032703882     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00801-5     Document Type: Conference Paper

References (5)

1. Laskow DA, Neylan III JF, Shapiro R, et al: Clin Transplant 12:489, 1998
2. Roth D, Colona J, Burke GW, et al: Transplantation 65:248, 1998
3. Vanrenterghem Y, Squifflet JP, Forsythe J, et al: Transplant Proc 30:1290, 1998
4. Shapiro R, Jordan ML, Scantlebury VP, et al: 16th Annual Meeting of the American Society of Transplant Physicians. Abstract 293, 1997
5. Undre NA, Van Hooff J, Christiaans M, et al: Transplant Proc 30:1299, 1998